SGH appoints medical tech fund analyst
Boutique fund manager SG Hiscock & Company has appointed Sophie Smith to the role of investment analyst, working on the recently-launched SGH Medical Technology fund.
Smith would directly report to portfolio manager, Rory Hunter, who said strong investor demand had driven the need for growing the capabilities of the fund.
“The domestic medical technology sector is growing exponentially. Sophie will work with the portfolio management team as they look to identify the most exciting opportunities in the industry, with a focus on high-quality growth companies,” Hunter said.
“As demand for diagnostic testing and healthcare services grows, we expect to see governments continue to incentivise innovation in the industry, resulting in fertile ground for emerging medical technology investment opportunities.
“We’re anticipating strong demand in the space for some time, and to have Sophie on board so soon after inception of the Fund is an exciting development for our clients.”
The fund invested in a mix of established and start-up medical technology companies, listed and unlisted, in Australia and New Zealand, and typically held between 40 and 60 investments.
According to FE Analytics, the fund had currently lost 2.79% but was only launched a month ago.
AUTHOR
Chris Dastoor
Recommended for you
The UK-based global asset manager has formed a new group executive committee to accelerate its growth strategy following the commencement of its new CEO this month.
Momentum Media has announced 26 winners across 10 individual and 15 group categories for its brand-new Australian AI Awards.
The financial services industry is currently “overwhelmed with quality and quantity of candidates”, Kaizen Recruitment explains, leading executives to face 12-month long recruitment processes.
Zenith Investment Partners has appointed an experienced research executive as its new group head of research following the departure of Bronwen Moncrieff.
